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Introduction: Studies on the role of the insertion/deletion (I/D) polymorphism of the gene coding for
angiotensin converting enzyme (ACE) in atherosclerosis have been inconsistent. In a meta-analysis, we
recently showed that this relationship is stronger in high risk populations. In this paper, we used a
combined functional and population based approach to investigate the gene–environment interaction of
the ACE I/D polymorphism in relation to carotid artery wall thickness.
Methods: The study was part of the Rotterdam Study, a prospective population based cohort study. In
5321 subjects, IMT was measured in the carotid arteries by ultrasonography and ACE genotype was
determined by size analysis of polymerase chain reaction products.
Results: In multiple regression analysis, I/D polymorphism and smoking were the main determinants for
plasma ACE activity (r2 = 0.28). There was a positive association between the D allele of the I/D
polymorphism and carotid artery thickness among current smokers (p = 0.03). Subjects carrying only one
of the risk factors (smoking or the D allele) did not show significant differences in IMT compared with the
non-/former smokers group carrying two II alleles, while carriers of both risk factors had significant higher
IMT. The association was not present in non-/former smokers.
Discussion: The results provide further evidence that genetic and environmental factors interact in the
formation of the arterial lesions. This study shows that large population based studies can be extremely
helpful in unravelling the genetic origin of complex diseases such as atherosclerosis.
A
ngiotensin converting enzyme (ACE) is a key compo-
nent in the renin angiotensin system, converting
angiotensin I to angiotensin II.1 It also inactivates
vasodilator bradykinin. Both peptides play central roles in
blood pressure regulation and are believed to be important in
the pathogenesis of cardiovascular diseases. ACE levels in
plasma and tissue are under genetic control.2–4 There is a
common insertion/deletion (I/D) polymorphism in the ACE
gene characterised by the presence or absence of a 287 bp alu
repeat. Subjects with the DD genotype have higher plasma
ACE activity compared with those with ID and II geno-
types.2 3 This finding predicts that carriers of this genotype
may have increased blood pressure and a higher prevalence of
cardiovascular diseases.
Findings on the association between the ACE I/D poly-
morphism and atherosclerosis using ultrasonographic
measurements of carotid arteries have been inconsistent.
Some studies showed a relation of atherosclerosis with
presence of the D allele,5–8 while others have failed to show
such association.9 10 The majority of the studies conducted
until now were based on relatively small sample sizes,
which may in part explain the inconsistency, particularly
when interactions were studied.11 A recent evaluation of
candidate gene studies in a meta-analysis demonstrated
that large studies are needed to show the effects of the
genes involved in complex traits.11 Recently, we performed a
meta-analysis of the association between this polymorphism
and carotid artery intima media thickness (IMT), using all
studies conducted until October 2002.12 When pooling the
data of 23 articles (9833 subjects), we found that carriers of
the DD genotype have an increased thickness of common
carotid IMT. The correlation was most pronounced in high
risk populations, suggesting gene–environment interac-
tions.12
From our meta-analysis, it is not clear which factor is
interacting with the ACE gene. As studies of gene–environ-
ment interactions are prone to false positive and negative
findings, we used a combined functional and population
based approach. To unravel the role of interactions of the ACE
I/D polymorphism with other factors, we aimed to identify
the non-genetic determinants of the renin angiotensin
system, specifically those associated with serum ACE activity.
We studied various vascular risk factors in relation to ACE
activity and found that only smoking was a determinant of
ACE activity in addition to the ACE gene. As a second step, we
investigated ACE and its interaction with smoking in relation
to carotid ultrasonographic measurements and found evi-
dence that smoking is a factor modifying the prevalence of
ACE related carotid artery lesions.
METHODS
Study population
This study is part of the Rotterdam Study, an ongoing
population based follow up study designed to investigate the
determinants of chronic diseases in the elderly; it has been
described in more detail elsewhere.13 In brief, baseline data
were collected between March 1990 and July 1993 from 7983
subjects, aged 55 years or older, living in Rotterdam, the
Netherlands.13 The study was approved by the medical ethics
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committee of Erasmus University, and written informed
consent was obtained from all participants.
All participants were interviewed at home by a trained
research assistant using computerised questionnaires, and
they subsequently visited the study centre. Smoking history
was assessed during the interview at home and patients were
categorised as never, former, or current smokers. At the study
centre, an extensive physical examination was performed on
each patient, including ultrasonography of the carotid
arteries. A blood sample was drawn, and serum and plasma
were stored at 280 C˚.
Carotid ultrasonography
Carotid atherosclerosis was assessed by duplex scan ultra-
sonography of the carotid arteries, using a 7.5 MHz linear
array transducer (ATL, Ultramark IV). Measurements of IMT
were performed offline from the still images recorded on
videotape. Details about this measurement have been
published previously.14 Briefly, the interfaces of the far and
near walls of the distal common carotid artery are marked
over a length of 10 mm. We used the average of the
measurements of three still images of both the left and right
arteries. Carotid IMT was determined as the mean of the
maximum IMT of near and far wall measurements of both
the left and right arteries. Results from a reproducibility
study of IMT measurements have been published elsewhere.15
The mean (SD) differences in common carotid IMT between
paired measurements of sonographers, readers, and visits
were 0.005 (0.09) mm, 0.060 (0.05) mm and 0.033
(0.12) mm, respectively.
We defined plaques as focal widening of the vessel wall
with protrusion into the lumen, composed of calcified or non-
calcified components. The protrusion was evaluated by eye,
without measuring the thickness of the lesions or of the
adjacent structure. The total plaque score reflected the total
number of sites with plaques and ranged from 0 to 6 (left and
right sided common carotid arteries, bifurcation, and internal
carotid arteries).
Laboratory assessments
Colorimetric determination of ACE activity was performed in
the stored plasma samples (280 C˚). Because of cost
considerations, ACE levels were assessed in a random group
of 215 individuals. The measurements were carried out with a
kit by Fujirebio Inc, which uses a p-hydroxy-Hip-His-Leu
substrate.16 Fluorimetric assay of ACE activity in plasma was
performed by measuring the release of His-Leu from the
substrates Hip-His-Leu and Z-Phe-His-Leu.17 18
DNA was isolated from the blood samples using standard
procedures (salting out).19 The II, ID, and DD genotypes were
detected by PCR according to the method of Lindpaintner
et al20 with some modifications. The insertion and deletion
alleles of the ACE gene were identified by using a set of
oligonucleotide primers flanking the polymorphic site in
intron 16. The final volume of the PCR mix was 20 ml,
containing 50 ng DNA as template and 16PCR buffer
(Gibco), 1.3 mmol/l MgCl2, 200 mmol/l dNTPs, 20 pmol
primer mix and 0.35 U Taq polymerase in a PE9600 PCR
machine. The thermocycling procedure was completely
identical to the method of Lindpaintner et al.20 The result of
amplification was a 319 bp and a 597 bp amplicon for the D
and I alleles respectively.
Because the D allele in heterozygous samples is preferen-
tially amplified, there is a tendency towards misclassification
of about 4–5% of ID genotypes to DD. In order to avoid this, a
second independent PCR was performed with a primer pair
that recognises an insertion specific sequence. To optimise
the second PCR, 10% DMSO, 0.35 U AmpliTaq Gold DNA
polymerase and 16 GeneAmp PCR Gold buffer (Applied
Biosystems) was added to the PCR mix with annealing
temperature of 67 C˚. The reaction yielded a 335 bp amplicon
only if the I allele was present. All reactions were performed
in 96 well plates and handled by a robot (Beckman BiomekH
2000).
In the post-PCR analyses, 10 ml of PCR product was loaded
onto a 3% agarose gel. Fragments were visualised using
etidium brominde staining and UV transillumination. Two
independent investigators interpreted the pictures from each
gel and all ambiguous samples were analysed a second time.
Statistical analyses
Hardy-Weinberg equilibrium was tested with the x2 test. We
analysed the distribution of conventional cardiovascular risk
factors among three genotype groups by x2 analyses for
dichotomous variables and by one way analysis of variance
for continuous variables. Multiple linear regression analysis
was used to analyse the relation between vascular risk factors
and ACE activity. The differences in ACE activity and IMT
between the smoking and genotype groups were tested using
the general linear model univariate procedure, adjusted for
age and gender. In addition, subjects were divided into two
groups based on the number of plaques in the carotid arteries
(0–2 and >3 plaques). Logistic regression was used to
estimate the adjusted odds ratios for the different genotype
groups using subjects with the II genotype as reference. No
adjustments were initially made for vascular risk factors such
as hypertension, as they may act as intermediate factors.
Interaction of the ACE genotype with smoking was tested
using a multiplicative model. All statistical analyses were
conducted using SPSS for Windows (version 11.0).
RESULTS
We performed our analysis on 5321 subjects for whom the
complete data for ACE genotyping, IMT measurements, and
smoking status were available. Data for at least one of the
variables were missing in the remaining subjects due to
logistic reasons; mainly because the subjects were too old or
disabled to visit the research centre for the examination. In
our sample, the frequency of the D allele was 53.3% and the
distribution of the genotypes and allele frequencies were in
Hardy-Weinberg equilibrium (II, 21.7%; ID, 49.9%; and DD,
28.3%; p = 0.82). Among the remaining subjects for whom
the genotype frequencies were available (n = 1548), no
deviation from Hardy-Weinberg equilibrium was observed.
Furthermore, there was no significant difference in the
genotype frequencies between the two samples (p = 0.44).
Table 1 shows the demographic characteristics of the
participants by ACE genotype. No significant differences were
found among the three genotypes with respect to classical
cardiovascular risk factors. The carriers of the D allele were
significantly older than the II carriers but the difference was
only 1.22 years. Furthermore, carriers of the DD genotype
had a significantly higher mean systolic blood pressure and a
higher mean of carotid IMT compared with the II genotype.
Although there was a slight increase in the percentage of
subjects with three or more plaques, the frequency did not
increase significantly in carriers of the D allele compared with
the II genotype (table 1).
In the sample of 212 individuals for whom both plasma
ACE activity and I/D genotypes were measured, the allele and
genotype proportions were consistent with Hardy-Weinberg
equilibrium (p = 0.48). In multiple linear regression analysis,
ACE I/D polymorphism and smoking were the only determi-
nants of plasma ACE activity (table 2). These two factors
together explained 28% of the variation in enzyme levels in
serum (r = 0.53, p,0.01). The activity of ACE was not
significantly different between former and non-smokers
(14.83 (3.57) and 15.58 (3.87) U/L respectively), therefore
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we combined these two groups. Overall, the ACE activity was
1.8 U/L higher in current smokers compared with non-/
former smokers (p,0.01). Although the difference in ACE
activity between smokers and non-/former smokers was
largest in the ID and DD group, it was not significantly
different from the difference in the II group (fig 1).
When studying the joint effect of smoking and the ACE
gene on IMT, there was a significant increase in mean carotid
IMT in those carrying the D allele in current smokers (p value
for trend was 0.04). The IMT difference (mean (SE)) between
DD and II genotypes in smokers was 0.26 (0.12) mm61021
(p = 0.03). In contrast, IMT was not significantly associated
with the D allele among non-/former smokers (fig 2). The p
value for interaction between ACE genotypes and smoking
status was 0.08. The differences between genotype groups in
smokers reduced but did not disappear when adjusted for
systolic blood pressure. Subjects carrying only one of the risk
factors (smoking or the D allele) did not show significant
differences in IMT compared with the genotype II non-/
former smokers group, while carriers of both risk factors had
significantly higher IMT (p,0.01).
The odds ratios of having three or more plaques in carotid
arteries in current smokers were 1.14 (95% confidence
interval (CI) 0.81 to 1.59) and 1.40 (95% CI 0.96 to 2.04)
for ID and DD genotypes respectively. This increase of odds
ratios with the number of the D alleles was borderline
significant (p = 0.07) while in non-/former smokers the odds
ratios remained the same between genotype groups.
Stratified analyses concerning the combined effect of ACE
polymorphism and other cardiovascular risk factors (hyper-
tension, hyperlipidaemia, diabetes, obesity, age, and gender)
on carotid IMT did not show any significant difference
among and between the stratified groups. In all the analyses,
the mean IMT difference between DD and II genotypes was
less than 0.20 mm61021 and did not reach significance level
(p.0.10).
DISCUSSION
In this study, we found a modest but significant association
between the ACE I/D polymorphism and carotid IMT in the
presence of smoking. In non-/former smokers, no significant
association between the ACE genotype and IMT was
observed.
This study is the largest population based study performed
on ACE I/D polymorphisms and carotid artery lesions. The
Table 2 Vascular risk factors and their association with
plasma ACE levels
Variable b SE p value
ACE I/D polymorphism* 2.71 0.35 ,0.01
Current smoking 1.92 0.61 ,0.01
Male sex 0.63 0.54 0.24
Age 20.07 0.06 0.20
Body mass index 0.07 0.08 0.37
Total cholesterol 20.19 0.23 0.42
HDL cholesterol 0.95 0.76 0.22
Systolic BP 20.01 0.02 0.84
Diastolic BP 20.02 0.04 0.56
b, Regression coefficient; SE, standard error of the coefficient
*Number of the D alleles used in the equation (II = 0, ID = 1 and DD = 2)
Figure 1 Plasma ACE activity in different genotypes stratified by
smoking status. Data are adjusted for age and gender. *Significantly
different from the genotype II non-/former smokers group.
Figure 2 Carotid intima media thickness (IMT) level in different
genotypes stratified by smoking status. Data are adjusted for age and
gender. *Significantly different from the genotype II non-/former
smokers group. Significantly different from the genotype II smokers
group.
Table 1 Demographic characteristics of subjects according to ACE I/D genotype
ACE genotype
II (n = 1156) ID (n = 2657) DD (n = 1508)
Men (%) 41.70 40.80 39.66
Age (years) 68.03 (8.53) 69.08 (8.67) 69.25 (8.89)
Body mass index 26.39 (3.82) 26.22 (3.65) 26.31 (3.63)
Current smokers (%) 22.88 23.60 20.82
Total cholesterol (mmol/L) 6.62 (1.28) 6.66 (1.17) 6.61 (1.21)
HDL cholesterol (mmol/L) 1.34 (0.35) 1.35 (0.35) 1.35 (0.37)
Systolic BP (mm Hg) 137.67 (21.61) 139.09 (22.66) 140.01 (22.84)
Diastolic BP (mm Hg) 73.48 (11.64) 73.53 (11.63) 73.73 (11.29)
Hypertension (%)* 31.78 36.03 35.05
Common carotid IMT (mm61021) 7.88 (1.53) 7.99 (1.59) 8.03 (1.59)
No. of carotid plaques >3 (%) 20.90 23.58 23.75
Continuous values are mean (SD). ACE, angiotensin converting enzyme; I/D, insertion/deletion; HDL, high density
lipoprotein; BP, blood pressure; IMT, intima media thickness
*Hypertension, defined as SBP>160 mm Hg or DBP>95 mm Hg or medication use
p,0.05 compared with II genotype
ACE gene–environment interaction 101
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next largest study, which used a sample size of 3657
individuals in Japan,21 failed to find a relation between ACE
and IMT. Difference in ethnicity could be a possible
explanation; however, the problem in comparing findings is
that the interaction between ACE polymorphism and smok-
ing was not studied by Mannami et al.21 Findings of other
studies on the interaction between the ACE gene and smoking
have not been consistent. An interaction between smoking
and ACE I/D genotype on atherosclerosis was reported in 1997
by Hibi et al,22 who showed a smoking associated effect of the
ACE genotype on the severity of coronary atherosclerosis.22
Another study23 found an association between ACE I/D and
carotid IMT only among non-/former smokers, particularly
those on chronic cardiovascular medication. Yet others failed
to find evidence for such an interaction.24
Genetic studies aiming to uncover gene interactions are
extremely prone to false positive and negative findings. To
obtain internal consistency in our study, we studied not only
the relation of the ACE gene to atherosclerosis but also to
ACE activity, which have been studied extensively with
regard to polymorphisms in the ACE gene.25–28 Since Rigat
et al2 reported in 1990 that the ACE I/D polymorphism
determines the plasma activity of the enzyme, many studies
have replicated this finding.3 8 10 Our data also confirm that
the presence of the deletion allele is significantly associated
with the plasma ACE activity. The ACE activity values in our
study were in the same range as those from other population
studies, which used the same method of measurement.8 29
Although ACE levels were determined in stored sera and
laboratory drift may have occurred, such drift is unlikely to be
associated with the ACE genotype.
To unravel the role of interactions of the ACE I/D
polymorphism with other vascular risk factors, we focused
on identifying the determinants in the renin angiotensin
system, specifically those associated with serum ACE activity.
In our population based study, we found that smoking is the
only other factor related to plasma ACE activity, suggesting
that they use the same pathways. The vascular risk factors
that might be related to serum ACE activity are not well
known. In one report, smoking and blood pressure30, and in
another, male sex and history of hypertension31correlated
with the serum ACE activity. In our sample, the I/D
polymorphism and smoking together explained 28% of the
variance in ACE activity. On average, current smokers had
1.8 U/L higher ACE activity in plasma. Although the
differences were not significant, in those carrying the ID
and DD genotypes the effect of smoking on ACE activity was
larger than in the II genotype. A possible effect of smoking on
cleavage secretion of ACE from the endothelial cells may
explain this finding.32 Additionally, there are indications that
nicotine increases expression of a number of genes in the
endothelium, including ACE.33
The values for IMT in our study strongly concurred with
those reported by Tabara et al, using a sample with the same
age.34 In order to test if the observed association between the
I/D polymorphism and carotid IMT in the presence of
smoking was through blood pressure, we adjusted our
analysis for systolic blood pressure. Our result suggests that
blood pressure does not fully explain the association.
Recently, it has been shown that the DD genotype is
associated with a significant blunting in vasodilatation
through nitric oxide (NO) pathways (due to increased
angiotensin II induced NO breakdown and/or reduced
bradykinin mediated NO release).35 This finding is
followed by other studies showing that smoking decreases
plasma NO level36 that may lead to impaired endothelium
dependent vasodilation.37 38 In addition, NO has important
anti-oxidative capacities, and smoking induces oxidative
stress by reducing concentrations of NO and other
antioxidants in plasma.39 Concurrently, carriers of the DD
genotype show a lower antioxidant response compared with
II and ID genotypes.40 The above observations suggest that
carriers of the DD genotype who smoke are likely to be at
higher risk of atherosclerosis.
Using a combined functional and population based
approach provides us with an a priori hypothesis for the
environmental factor(s) that may interact with the gene.
However, the question remains if other environmental factors
can show the same pattern of interaction. The results of the
stratified analyses showed no significant evidence for joint
effect of the ACE polymorphism and other factors, prompting
smoking as the best candidate for this interaction.
In summary, we found a positive association between the
D allele of the I/D polymorphism and carotid IMT in the
presence of smoking. This association provides further
evidence that genetic and environmental factors interact in
the formation of the arterial lesions. There may be various
pathways underlying the observation of an effect of the ACE
gene on IMT in smokers only, but on the basis of the present
results it is not possible to fully explain the underlying
mechanism. Our findings remain to be confirmed in future
studies.
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